UTHR
UTHR
NASDAQ · Biotechnology

United Therapeutics Corp

Large-Cap Stocks Blue Chip Stocks Biotech Stocks Healthcare Stocks
$544.33
+6.03 (+1.12%)
As of Jun 23, 9:39 PM ET ·
Analyst Consensus
Strong Buy
22
Analysts
High
Coverage
Buy 18 82%
Hold 4 18%
Sell 0 0%
Price Target
Analyst Price Target -83.7% upside
Low Target $65.70
Average Target $88.53
High Target $121.74
Current Price $544.33
Current
$544.33
Target
$88.53
$65.70 $88.53 avg $121.74
Scenario Analysis
Bear Case
$65.70
-87.9%
Low target
Base Case
$88.53
-83.7%
Avg target
Bull Case
$121.74
+-77.6%
High target
Risk/Reward
0.9x
Unfavorable
Price in Context
52-Week High
$609.35
-10.7% from high
52-Week Low
$272.12
+100.0% from low
50-Day SMA
$485.49
+12.1% vs SMA
200-Day SMA
$394.55
+38.0% vs SMA
RSI (14)
60.3
Neutral
Target vs 52W High
$88.53
-85.5% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
 Strong Buy 40 78% $257.58 +9.7%
AMGN
Amgen Inc
 Hold 44 50% $190.87 -45.0%
GILD
Gilead Sciences Inc
 Strong Buy 39 82% $362.68 +190.0%
VRTX
Vertex Pharmaceuticals Inc
 Strong Buy 40 83% $438.34 -6.4%
REGN
Regeneron Pharmaceuticals
 Buy 38 71% $76.80 -87.6%
ALNY
Alnylam Pharmaceuticals Inc
 Strong Buy 37 76% $102.31 -64.5%
RVMD
Revolution Medicines Inc
 Strong Buy 27 96% $114.11 -32.7%
NTRA
Natera Inc
 Strong Buy 27 89% $142.91 -39.1%